Makarova V A, Geskin Iu F, Shirokova T A, Zubzhitskiĭ Iu M
Zh Nevropatol Psikhiatr Im S S Korsakova. 1988;88(2):24-7.
Using complement fixation test (CFT) in cold, the authors measured the circulating tissue antigens of the brain and liver in 50 subjects (22 patients with hepatocerebral dystrophy, 18 with multiple sclerosis and 10 healthy subjects). The total circulating levels of liver and brain antigens were found to be dependent on the activity and progression of the pathological process in these organs. The CFT may be recommended as an additional test for diagnosing the destructive process in the brain and liver of patients with hepatocerebral dystrophy and multiple sclerosis and for assessing the efficacy of the conducted treatment.
